Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer

Completed · Phase 1

Conditions studied: Colorectal Cancer

In brief

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of nitric oxide-releasing acetylsalicyclic acid may prevent colorectal cancer. PURPOSE: This randomized phase I trial is studying the side effects and best dose of nitric oxide-releasing acetylsalicyclic acid in preventing colorectal cancer in patients at high risk of colorectal cancer.

Key facts

Study ID

NCT00331786

Run by

Stony Brook University

People needed

240

Starts

2006-07-01

Last updated by the study team

2009-02-09

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Stony Brook University Cancer Center — Stony Brook, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.